Hemoglobinopathy correction with CRISPR or not; gene therapy is the solution
Hemoglobin (Hb) disorders or hemoglobinopathies are groups of blood conditions involving inherited genetic diseases - mostly as single-gene autosomal recessive - that lead to the formation of abnormal Hb structure or inadequate to no production of globin chains in Hbs. Disorders of Hb are a global c...
Saved in:
Main Authors: | Bader Al Alwan (Author), Arwa A Alsubait (Author), Bahauddeen M Alrfaei (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction
by: Emily Xia, et al.
Published: (2018) -
Cancer Stem Cell-Exosomes, Unexposed Player in Tumorigenicity
by: Batla S. Al-Sowayan, et al.
Published: (2020) -
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
by: Wei-Jing Dai, et al.
Published: (2016) -
Gene editing and therapy - A new tool: CRISPR/Cas9
by: Ashok M. Patil
Published: (2019) -
Therapeutic gene correction for Lesch-Nyhan syndrome using CRISPR-mediated base and prime editing
by: Gayoung Jang, et al.
Published: (2023)